The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLLIan W. Flinn, Stephan Stilgenbauer, Peter Hillmen et al.|Blood|2018Cited by 341
Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron diseaseTammy Nguyen, Janet M. Shaw, Sang Su Oh et al.|Proceedings of the National Academy of Sciences|2014Cited by 223
Cross‐regulation among disparate antibiotic biosynthetic pathways of <i>Streptomyces coelicolor</i>Jianqiang Huang, Stanley N. Cohen, Jing Shi et al.|Molecular Microbiology|2005Cited by 214
Inhibition of FAK kinase activity preferentially targets cancer stem cellsVihren N. Kolev, David T. Weaver|Oncotarget|2017Cited by 77
Genome plasticity in <i>Streptomyces</i>: identification of 1 Mb TIRs in the <i>S. coelicolor</i> A3(2) chromosomeDavid T. Weaver, Camilla M. Kao, Jianqiang Huang et al.|Molecular Microbiology|2004Cited by 65